Dunger D B, Salgin B, Ong K K
University Department of Paediatrics, University of Cambridge, Addenbrooke's Hospital, Box 116, Cambridge CB2 2QQ, UK.
Proc Nutr Soc. 2007 Aug;66(3):451-7. doi: 10.1017/S0029665107005721.
Size at birth and patterns of postnatal weight gain have been associated with adult risk for the development of type 2 diabetes in many populations, but the putative pathophysiological link remains unknown. Studies of contemporary populations indicate that rapid infancy weight gain, which may follow fetal growth restriction, is an important risk factor for the development of childhood obesity and insulin resistance. Data from the Avon Longitudinal Study of Pregnancy and Childhood shows that rapid catch-up weight gain can lead to the development of insulin resistance, as early as 1 year of age, in association with increasing accumulation of central abdominal fat mass. In contrast, the disposition index, which reflects the beta-cells ability to maintain insulin secretion in the face of increasing insulin resistance, is much more closely related to ponderal index at birth than postnatal catch-up weight gain. Infants with the lowest ponderal index at birth show a reduced disposition index at aged 8 years associated with increases in fasting NEFA levels. The disposition index is also closely related to childhood height gain and insulin-like growth factor-I (IGF-I) levels; reduced insulin secretory capacity being associated with reduced statural growth, and relatively short stature with reduced IGF-I levels at age 8 years. IGF-I may have an important role in the maintenance of beta-cell mass, as demonstrated by recent studies of pancreatic beta-cell IGF-I receptor knock-out and adult observational studies indicating that low IGF-I levels are predictive of subsequent risk for the development of type 2 diabetes. However, as insulin secretion is an important determinant of IGF-I levels, cause and effect may be difficult to establish. In conclusion, although rapid infancy weight gain and increasing rates of childhood obesity will increase the risk for the development of insulin resistance, prenatal and postnatal determinants of beta-cell mass may ultimately be the most important determinants of an individual's ability to maintain insulin secretion in the face of increasing insulin resistance, and thus risk for the development of type 2 diabetes.
在许多人群中,出生时的体重及出生后体重增加模式与成人患2型糖尿病的风险相关,但假定的病理生理联系仍不明晰。对当代人群的研究表明,婴儿期体重快速增加(可能继发于胎儿生长受限)是儿童期肥胖和胰岛素抵抗发生的重要危险因素。雅芳亲子纵向研究的数据显示,快速追赶性体重增加可早在1岁时就导致胰岛素抵抗的发生,这与腹部中央脂肪量的增加有关。相比之下,反映β细胞在胰岛素抵抗增加时维持胰岛素分泌能力的处置指数,与出生时的体重指数比与出生后追赶性体重增加的关系更为密切。出生时体重指数最低的婴儿在8岁时处置指数降低,与空腹非酯化脂肪酸(NEFA)水平升高有关。处置指数还与儿童期身高增长和胰岛素样生长因子-I(IGF-I)水平密切相关;胰岛素分泌能力降低与身高增长减少有关,而8岁时身材相对矮小与IGF-I水平降低有关。近期对胰腺β细胞IGF-I受体敲除的研究以及成人观察性研究表明,低IGF-I水平可预测随后发生2型糖尿病的风险,这表明IGF-I可能在维持β细胞量方面发挥重要作用。然而,由于胰岛素分泌是IGF-I水平的重要决定因素,因果关系可能难以确定。总之,尽管婴儿期体重快速增加和儿童肥胖率上升会增加胰岛素抵抗发生的风险,但β细胞量的产前和产后决定因素可能最终是个体在面对胰岛素抵抗增加时维持胰岛素分泌能力的最重要决定因素,从而也是发生2型糖尿病风险的最重要决定因素。